共 84 条
[11]
Kabawat SE(2000)Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity Am J of Manag Care 6 766-780
[12]
Dupree WB(1998)Where’s the high-grade neoplasia? The importance of minimally abnormal Papanicolaou diagnoses Obstet Gynecol 91 73-76
[13]
Suprun HZ(1989)The Papanicolaou test for cervical cancer detection: a triumph and a tragedy JAMA 261 737-743
[14]
Beckwith DG(1997)Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening Obstet Gynecol 90 278-284
[15]
Shane JJ(1997)The ThinPrep Pap Test: a review of clinical studies Acta Cytol 41 30-38
[16]
Lucente V(1998)ThinPrep Papanicolaou testing to reduce false-negative cervical cytology Arch Pathol Lab Med 122 139-144
[17]
Fender M(1999)Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results JAMA 281 1605-1610
[18]
Schaffer P(1998)Evaluation of the ThinPrep Pap Test in clinical practice: a seven-month, 16,314-case experience in northern Vermont Acta Cytol 42 203-208
[19]
Dellenbach P(1997)Evaluation of the ThinPrep Pap Test as an adjunct to the conventional Pap smear Med J Aust 167 466-469
[20]
Gay J(1998)Dépistage des cancers du col de l’utérus en France [Screening for cancers of the uterine cervix in France] Gynécologie-Obstétrique Pratique 105 1-1008